This review synthesizes data from 22 rigorously selected studies focusing on the neonatal period—the foundational window during which the gut microbiome undergoes rapid development and is particularly amenable to external influences. Breastfeeding, long celebrated for its immunological and nutritional benefits, now emerges under a new light as a significant contributor to the microbial and genetic milieu of the neonatal intestine. The breast milk microbiome itself harbors a diverse array of bacteria, some of which carry ARGs. This discovery challenges the traditional perception of breast milk as a purely protective agent, instead revealing its nuanced role as a vector for both beneficial microorganisms and potential resistance determinants.

The studies underscore that breast milk supplies a repository of bacteria profoundly shaping the early-life microbial community structure. Notably, the research indicates that breast milk is not just passively imparted but actively involved in seeding the neonatal gut. This vertical transmission route facilitates the transfer of commensal microbes that may harbor beneficial traits while simultaneously opening avenues for ARG propagation. Astonishingly, the diversity and resistance profiles of these microbes in breast milk are influenced by myriad maternal factors including antibiotic usage, dietary patterns, and overall health status, highlighting the complexity of mother-infant microbial interconnections.

Intriguingly, while several studies document breast milk as a vector for ARGs, exclusive breastfeeding regimes appear to attenuate the colonization efficiency of multidrug-resistant organisms (MDROs) in neonates. Human milk is rich in bioactive compounds such as human milk oligosaccharides (HMOs), lactoferrin, and immunoglobulins—molecules known to foster beneficial bacterial growth and inhibit pathogenic bacteria. This bioactive milieu not only supports the establishment of a healthy commensal community but also constrains the horizontal gene transfer mechanisms that underlie the spread of resistance plasmids within the gut ecosystem.

Elucidating the mechanistic underpinnings of these observations remains a frontier challenge. Current research delineates two opposing trajectories: on one hand, breast milk mediates a protective environment that discourages the establishment of resistant pathogens, and on the other, it may inadvertently introduce resistance genes through its resident microbiota. This paradox underscores the need for advanced molecular and metagenomic investigations that can dissect the precise genetic exchanges occurring within the neonatal gut, leveraging next-generation sequencing and functional genomics to map ARG networks with high resolution.

Maternal influences on breast milk composition emerge as pivotal modifiers determining AMR outcomes in neonates. Prior maternal antibiotic exposure, for example, has been linked to altered microbial profiles in milk, enriching for resistant strains and genes. Moreover, lifestyle factors such as diet, hygiene, and health status intricately weave the microbial tapestry of breast milk, further shaping the neonatal resistome. This dynamism suggests that interventions targeting maternal health before and during lactation could indirectly pivot neonatal AMR trajectories, opening avenues for preventative strategies anchored in maternal care.

The implications of these findings stretch beyond academic inquiry into tangible clinical and public health domains. Given the heightened vulnerability of neonates, especially preterm and low-birth-weight infants, to infections caused by resistant pathogens, understanding the role of breastfeeding in this context is critical. Breastfeeding promotion remains a cornerstone of neonatal care globally, yet this review prompts a reconsideration of maternal antibiotic stewardship and monitoring of breast milk microbiota as integral components of AMR containment frameworks.

The research also sheds light on horizontal gene transfer, a fundamental mechanism driving AMR spread within microbial communities. Within the neonatal gut, mobile genetic elements such as plasmids, transposons, and integrons facilitate ARG dissemination. Bioactive components of breast milk appear to modulate these processes, potentially by influencing microbial community stability or by directly suppressing conjugation events. Decoding these complex interactions at the molecular level could spur the development of novel therapeutics designed to impede ARG transmission without compromising microbial diversity.

Significantly, the review highlights substantial knowledge gaps. While correlations between breast milk microbiota and neonatal ARG profiles have been observed, causal relationships remain tenuous. Longitudinal cohort studies employing multi-omics approaches will be pivotal to untangle temporal dynamics and causal pathways. Furthermore, the influence of environmental exposures, delivery mode, and neonatal antibiotic administration on these interactions warrant rigorous exploration to refine our understanding of neonatal resistome modulation.

Emerging technologies such as single-cell genomics and spatial transcriptomics hold promise to revolutionize the field. These tools can illuminate microbial-host interactions within gut niches at unprecedented granularity, revealing how breast milk-derived microbes establish residency, interact with the host immune system, and transfer resistance elements. Harnessing such insights could catalyze the design of precision microbiome therapies tailored to safeguard neonatal health while combating AMR proliferation.

In sum, breastfeeding stands at a fascinating crossroads in the context of neonatal antimicrobial resistance. It embodies a complex biological system that supports neonatal immune maturation and nutritional needs while concurrently serving as a vector for microbial and genetic elements with potential resistance implications. This duality calls for nuanced, interdisciplinary research that integrates microbiology, immunology, genomics, and clinical sciences to delineate strategies optimizing neonatal outcomes amid the looming AMR crisis.

As the fight against antimicrobial resistance intensifies, this systematic review underscores the critical importance of considering maternal-infant microbial transmission pathways in neonatal health policies. Breastfeeding-centered interventions, combined with maternal health optimization and antibiotic stewardship, represent promising avenues to mitigate AMR risks from the very outset of life. Future research efforts must harness advanced molecular tools and longitudinal clinical investigations to establish definitive causal links and actionable insights that inform global neonatal care paradigms.

In a world where antimicrobial resistance threatens to undermine decades of medical progress, illuminating the subtle yet profound influence of breastfeeding on neonatal resistomes offers a beacon of hope. By understanding and harnessing the intricate mother-infant microbial transmissions, the scientific community stands poised to safeguard the health of future generations against the silent pandemic of antimicrobial resistance.

Subject of Research: The role of breastfeeding in modulating antimicrobial resistance and antimicrobial resistance gene transfer in neonates.

Article Title: The role of breastfeeding in modulating antimicrobial resistance in neonates: a systematic review.

Article References:
Mathkor, D.M., Aldairi, A.F., Faidah, H. et al. The role of breastfeeding in modulating antimicrobial resistance in neonates: a systematic review. Pediatr Res (2026). https://doi.org/10.1038/s41390-026-04902-y

Image Credits: AI Generated

DOI: 21 March 2026

The gut microbiome, a complex community of microorganisms residing within our digestive tracts, has garnered immense scientific interest for its far-reaching implications on health and disease. For preterm infants, whose physiological development is still incomplete, the establishment of a beneficial microbiome is not merely a biological curiosity but a critical factor influencing outcomes ranging from immune system maturation to resistance against infections. The study’s focus on feeding very preterm infants human milk at volumes of 60 ml/kg/day or more within a narrow neonatal window sheds light on how early nutritional interventions can accelerate and optimize microbial colonization processes.

Upon commencing the study, researchers employed rigorous randomized controlled methodologies to minimize confounding variables, carefully assigning very preterm infants to receive either higher or lower volumes of human milk shortly after birth. The meticulous design allowed for discerning the direct effects attributable to feeding volumes while monitoring an array of clinical and microbiological parameters over time. Utilizing advanced sequencing techniques to analyze stool samples, the team painted a detailed portrait of the evolving microbial communities, revealing striking differences aligned with feeding regimens.

Central to the findings was the observation that infants receiving the higher volume threshold displayed a more diverse and stable gut microbiome compared to their counterparts. Early high-volume milk feeding appeared to facilitate the rapid colonization of beneficial bacterial taxa commonly associated with gut health and barrier function. These microbes, including various Bifidobacterium and Lactobacillus species, are known for their capacity to metabolize human milk oligosaccharides—complex sugars abundant in breast milk—and produce metabolites that promote intestinal integrity and immunomodulation.

Beyond microbial diversity, the study highlighted critical temporal dynamics. The window within the first 36 hours after birth emerged as a pivotal period where the gut environment is particularly receptive to colonization by these advantageous microbes. At this early stage, the gastrointestinal tract is relatively sterile, and the neonate’s immune milieu is highly malleable. This confluence sets the stage for either beneficial or adverse microbial patterns that might influence health trajectories. The data suggest that prompt initiation of sufficient volumes of human milk can effectively steer the microbiome’s establishment toward a profile supportive of long-term well-being.

Interestingly, the researchers also documented a reduction in the abundance of potentially pathogenic bacteria among infants in the early high-dose milk group. Organisms often implicated in necrotizing enterocolitis (NEC) and late-onset sepsis—a major causes of morbidity in preterm infants—were significantly suppressed. This finding not only reinforces the protective qualities of human milk but also implies that dosage and timing are critical factors determining its efficacy as a microbial modulator.

The implications for neonatal intensive care units (NICUs) are profound. This study advocates for protocols that prioritize early aggressive feeding strategies with maternal milk or donor human milk when maternal supply is insufficient. By instituting feeding regimens reaching or exceeding 60 ml/kg/day within the crucial 36-hour timeframe, NICUs might improve clinical outcomes by nurturing a fortified gut microbiota that lowers infection risk and promotes gut health.

Furthermore, this research adds a nuanced layer to the ongoing discourse surrounding the optimization of feeding practices in neonatal care. While human milk has long been championed for its nutritional and immunological virtues, this study quantitatively anchors the importance of volume and timing, providing actionable insights that can be institutionally standardized. The findings invite reconsideration of current feeding guidelines that often prioritize gradual volume increases over rapid attainment of target feeding volumes.

Importantly, the study also contributes to understanding the interplay between feeding strategies and antibiotic exposure. Antibiotics, commonly administered to preterm infants as a precaution, can disrupt microbial colonization. By advancing early feeding volumes of human milk, there is potential to mitigate these antibiotic-associated perturbations, restoring beneficial microorganisms more swiftly and reducing the window of vulnerability to colonization by harmful pathogens.

As the field advances, the multidimensional benefits of early human milk feeding extend beyond microbial composition to include biomarkers of gut barrier function and systemic inflammation. Future investigations inspired by this study might explore how early volume thresholds influence metabolites and immune signaling molecules, potentially unraveling mechanisms linking nutrition-driven microbiome shifts to clinical outcomes such as growth metrics and neurodevelopmental milestones.

The technological strides enabling this research—such as high-throughput sequencing and bioinformatics pipelines—empower scientists to dissect microbial communities with unprecedented precision. The ability to correlate microbial taxa with clinical variables facilitates a more holistic understanding of neonatal physiology, moving infant care into an era where microbiome health is a measurable and modifiable treatment target.

Critically, the study champions the irreplaceable value of human milk. While formula feeding remains necessary in many contexts, human milk uniquely offers a complex, bioactive matrix capable of shaping microbial colonization favorably. The authors emphasize that early provision of adequate volumes is necessary to unlock these benefits, urging clinical teams to develop infrastructural supports including lactation assistance and milk banking to meet this goal.

In a broader biomedical context, these findings resonate with emerging themes about early-life exposures setting foundational health trajectories. They echo and extend the Developmental Origins of Health and Disease (DOHaD) hypothesis by underscoring how microbial ecosystems established in the first days post-birth have ripple effects into future disease risk profiles, potentially influencing metabolic, allergic, and neurobehavioral health.

Moreover, the study’s methodology and conclusions may inspire cross-disciplinary collaborations—from neonatology to microbiology, immunology, and nutrition science—to design integrative interventions. Precision nutrition tailored to microbiome maturation could revolutionize neonatal care paradigms, transforming clinical outcomes for preterm infants who frequently face lifelong health challenges.

As neonatal research gravitates toward personalized and preventive medicine, the role of human milk in microbiome development stands as a beacon of biological simplicity harnessed for sophisticated health engineering. The evidentiary weight carried by this study provides a clarion call for clinicians, healthcare systems, and policymakers to advocate steadfastly for early, adequate human milk feeding volumes as a cornerstone of neonatal health optimization.

These findings also present a compelling narrative for public health messaging directed at families of preterm infants. Educating parents about the profound influence of milk volume and timing on their child’s microbial and immune development may empower engagement with lactation services and milk donation programs, creating a virtuous cycle of improved neonatal nutrition and microbiome resilience.

Ultimately, the work of Salas, Stewart, and Young illuminates a critical, actionable pathway to recalibrate neonatal care. By aligning feeding practices with the biological imperatives of microbial colonization, this research holds promise for reducing the burden of preterm infant morbidity and paving the way toward healthier developmental outcomes in this fragile population. The scientific and clinical communities eagerly await further data as this vital field evolves, poised to transform how early nutrition shapes the foundation of lifelong health.

Subject of Research: Early gut microbiome development in very preterm infants influenced by human milk feeding volume and timing.

Article Title: Early gut microbiome composition of very preterm infants randomised to receive human milk volumes of 60 ml/kg/day or more within the first 36 hours after birth.

Article References:
Salas, A.A., Stewart, C.J. & Young, G.R. Early gut microbiome composition of very preterm infants randomised to receive human milk volumes of 60 ml/kg/day or more within the first 36 hours after birth. Pediatr Res (2025). https://doi.org/10.1038/s41390-025-04456-5

Image Credits: AI Generated

DOI: https://doi.org/10.1038/s41390-025-04456-5

Breast milk is widely recognized as the gold standard for infant nutrition, providing a complex blend of nutrients, immunological factors, and bioactive molecules that promote healthy growth and development. Within this rich matrix, prebiotics and natural probiotics play a vital role by nurturing a balanced gut microbiota that is essential for the infant’s immune system maturation and metabolic programming. Given this inherent benefit, the authors question if additional probiotic supplementation in breast-fed term infants is redundant or if it could confer additive advantages, potentially enhancing or accelerating these processes.

The microbial colonization of the infant gut begins at birth and is profoundly influenced by mode of delivery, feeding choice, and environmental exposures. Vaginal birth and exclusive breastfeeding encourage the establishment of beneficial bacterial strains such as Bifidobacteria and Lactobacilli, which dominate the gut microbiota and contribute to immune modulation and gut barrier function. Premkumar and Pammi critically examine how supplemental probiotics might alter or augment this natural colonization pattern and whether their use in breast-fed infants translates to measurable health benefits.

From a mechanistic perspective, probiotics are live microorganisms that, when administered in adequate amounts, confer health benefits to the host by enhancing gut barrier integrity, modulating immune responses, competing with pathogenic microbes, and influencing systemic inflammation. The authors detail current understandings of these mechanisms, emphasizing that breast milk itself contains not only prebiotic human milk oligosaccharides but also live microbial populations, raising the question of how exogenous probiotics interface with these naturally occurring factors.

The clinical evidence for probiotic use in infants has largely focused on those born preterm, formula-fed, or at heightened risk of intestinal and systemic infections. In contrast, studies examining probiotics in healthy breast-fed term infants are sparse and show mixed outcomes. Premkumar and Pammi review randomized controlled trials and observational studies that report varying effects on colic, eczema, allergic sensitization, and gastrointestinal infections, highlighting the methodological heterogeneity and small sample sizes that limit definitive conclusions.

Notably, the authors emphasize the balance researchers must strike between potential benefits and risks. Despite probiotics’ generally excellent safety profile, concerns remain regarding strain-specific effects, dosage, timing of administration, and the possibility of introducing microbial dysbiosis or antibiotic resistance genes. For healthy infants already thriving on breast milk, the cost-benefit ratio may not justify routine supplementation, particularly when regulatory oversight of probiotic products is inconsistent.

Emerging technologies such as metagenomics and metabolomics have allowed for unprecedented insights into the infant gut microbiome and its dynamic ecosystem, providing a nuanced framework to understand how probiotics might exert strain-specific and context-dependent effects. The article underlines the need for precision medicine approaches, including identifying biomarkers predictive of probiotic responders versus non-responders and tailoring interventions accordingly.

Furthermore, Premkumar and Pammi address the impact of environmental variables and maternal health on infant microbiota development. Factors such as maternal diet, antibiotic use, and geographic location contribute to significant variability, which probiotics alone may not overcome. Breast milk continues to be the most modifiable and potent factor influencing infant microbiota composition, underscoring the importance of supporting and promoting breastfeeding practices over unnecessary supplementation.

An important consideration discussed is the commercial and cultural forces driving probiotic promotion. With a rapidly expanding probiotic market, especially within infant nutrition products, there is a risk of overmedicalizing infancy and creating parental anxiety regarding the “optimal” gut microbiome. The authors advocate for evidence-based guidelines and regulatory frameworks that prevent exaggerated health claims unsupported by rigorous trials.

The article also touches upon future research needs, including large-scale, multicenter studies focusing on long-term outcomes such as immune tolerance, metabolic health, and neurodevelopmental trajectories. Integration of microbiome data with host genetic and environmental factors could illuminate probiotic effects beyond immediate gastrointestinal health, potentially revealing subtle programming effects affecting life course disease risk.

In conclusion, the investigation by Premkumar and Pammi provides a critical and nuanced appraisal of probiotic supplementation in breast-fed healthy term infants. They caution that despite considerable enthusiasm, routine probiotic use in this population remains an open question, with current evidence insufficient to categorize it as either an imperative intervention or a superfluous addition. Their work calls for careful clinical judgment, individualized assessment, and ongoing robust scientific inquiry to ensure that probiotic use aligns with demonstrable health benefits without displacing established, evidence-based infant feeding practices.

By elucidating the complex interactions between breast milk, the infant microbiome, and probiotics, this research contributes a vital perspective to pediatric nutrition and microbiome science. As we advance toward personalized nutrition and medicine, understanding who may truly benefit from probiotic supplementation—and under what circumstances—will be key to optimizing infant health and preventing the overuse of interventions in this vulnerable population.

Subject of Research: Probiotic supplementation in breast-fed healthy term infants and its clinical necessity.

Article Title: Probiotics in breast-fed healthy term infants: imperative or superfluous?

Article References:
Premkumar, M.H., Pammi, M. Probiotics in breast-fed healthy term infants: imperative or superfluous?. Pediatr Res (2025). https://doi.org/10.1038/s41390-025-04485-0

Image Credits: AI Generated

DOI: https://doi.org/10.1038/s41390-025-04485-0